Skip to main content

Table 2 Reasons for not seeking care in cannabis clinics among individuals who reported self-medication with cannabis in an online survey in Quebec from November 2020 to January 2021 (n = 489)

From: A description of self-medication with cannabis among adults with legal access to cannabis in Quebec, Canada

Reason Genderab Ageb Type of cannabis use Total
Men (n = 210) Women (n = 213) p-value 21-34 (n = 224) > 34 (n = 214) p-value Medical only (n = 113) Medical + recreational (n = 326) p-value
Never received information 102 (48.57) 122 (57.28) 0.07 135 (60.27) 97 (45.33) 0.002 60 (53.10) 172 (52.76) 0.95 232 (52.85)
Complexity of the process 98 (46.67) 69 (32.39) 0.003 96 (42.86) 78 (36.45) 0.17 38 (33.63) 137 (42.02) 0.13 175 (39.86)
Difficulty accessing medical cannabis clinics 61 (29.05) 36 (16.90) 0.003 60 (26.80) 42 (19.63) 0.07 20 (17.70) 82 (25.15) 0.11 102 (23.23)
The delay before obtaining cannabis is too long 43 (20.48) 24 (11.27) 0.009 44 (19.64) 27 (12.62) 0.04 16 (14.16) 55 (16.87) 0.50 71 (16.17)
Higher price of cannabis 35 (16.67) 16 (7.51) 0.004 23 (10.27) 30 (14.02) 0.23 16 (14.16) 37 (11.35) 0.43 53 (12.07)
Poor customer service with the clinics 7 (3.33) 5 (2.35) 0.54 8 (3.57) 6 (2.80) 0.65 7 (6.19) 7 (2.15) 0.03 14 (3.19)
Not satisfied with the characteristics of products 24 (11.43) 10 (4.69) 0.01 17 (7.59) 20 (9.35) 0.51 12 (10.62) 25 (7.67) 0.33 37 (8.43)
The inability to choose the products yourself 41 (19.52) 39 (18.31) 0.75 49 (21.88) 34 (15.89) 0.07 16 (14.16) 67 (20.55) 0.13 83 (18.91)
Follow-up with a doctor does not suit me 45 (21.43) 38 (17.84) 0.35 53 (23.66) 36 (16.82) 0.07 11 (9.73) 78 (23.93) 0.001 89 (20.27)
Refusal of physician 13 (6.19) 22 (10.33) 0.12 14 (6.25) 21 (9.81) 0.16 11 (9.73) 24 (7.36) 0.42 35 (7.97)
Other reasonsc 21 (10.00) 21 (9.86) 0.96 20 (8.93) 23 (10.75) 0.52 15 (13.27) 28 (8.59) 0.15 43 (9.79)
  1. Comparisons between groups were made using chi-square tests and p-value calculated. A p-value <0.05 was considered as statistically significant
  2. aSixteen participants who reported other gender were not included in the stratification
  3. bFifty participants whose answer was “I don’t know” were not considered in the denominator, in addition to one missing for age categorization
  4. cOther reasons included the following: treated condition does not require a medical prescription (minor symptoms), in the process to obtain medical cannabis; no prescription, combine medical access with SQDC access, never engaged in the process/does not feel the need for a medical prescription, stigmatization by the healthcare system, legal access at SQDC thus no need to go in clinics, no clinic near their location